DW
Daniel R. Wong
Pfizer, UCSF, University of California, Berkeley
Research areas: Medicine · Cardiology and Cardiovascular Medicine · Aortic Disease and Treatment Approaches · Cardiac Valve Diseases and Treatments · Infective Endocarditis Diagnosis and Management
Employment
-
Pfizer Machine Learning Scientist2022 - Present
-
UCSF Graduate Student2017 - Present
Education
-
UCSF PhD2017 - Present
-
UC Berkeley B.A. Computer Science; B.A. Molecular and Cellular Biology2013 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Phenotypic reversion and target prioritization for cellular inflammation via representation learning with foundation models Save
- Phenotypic reversion and target prioritization for cellular inflammation via representation learning with foundation models Save
- Simple controls exceed best deep learning algorithms and reveal foundation model effectiveness for predicting genetic perturbations Save
- Simple controls exceed best deep learning algorithms and reveal foundation model effectiveness for predicting genetic perturbations Save
- Learning fast and fine-grained detection of amyloid neuropathologies from coarse-grained expert labels Save
- Learning fast and fine-grained detection of amyloid neuropathologies from coarse-grained expert labels Save
- Deep representation learning determines drug mechanism of action from cell painting images Save
- Deep learning from multiple experts improves identification of amyloid neuropathologies Save
- Deep Representation Learning Determines Drug Mechanism of Action from Cell Painting Images Save
- Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics Save
- Deep learning from multiple experts improves identification of amyloid neuropathologies Save
- Trans-channel fluorescence learning improves high-content screening for Alzheimer’s disease therapeutics Save
- Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding Save
- Prototype of running clinical trials in an untrustworthy environment using blockchain Save